Qiagen Earnings, Revenue beat In Q1

  • Investing.com
Qiagen Earnings, Revenue beat In Q1
Credit: © Reuters.

Investing.com - Qiagen reported on Monday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Qiagen announced earnings per share of $0.5466 on revenue of $469.75M. Analysts polled by Investing.com anticipated EPS of $0.5252 on revenue of $464.11M.

Qiagen shares are down 5% from the beginning of the year and are trading at $40.045 , down-from-52-week-high.They are under-performing the STOXX 600 which is up 10.25% from the start of the year.

Qiagen follows other major Healthcare sector earnings this month

Qiagen's report follows an earnings missed by Siemens Healthineers on Monday, who reported EPS of $0.44 on revenue of $3.97B, compared to forecasts EPS of $0.4647 on revenue of $3.9B.

Dermapharm had missed expectations on Tuesday, April 13, 2021 with first quarter EPS of $0.45 on revenue of $216.7M, compared to forecast for EPS of $0.51 on revenue of $208.85M.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100